Omeros Stock

Omeros EBIT per Employee

The EBIT per Employee of Omeros (OMER) as of Aug 6, 2026 is -475,953.49 USD. In the previous year, EBIT per Employee was -656,038.76 USD — a change of -27.45% (higher).

EBIT per Employee

-475,953.49USD

YoY

-27.45%

Last updated:

EBIT per Employee of Omeros is 2026 -475,953.49 USD. EBIT per Employee of Omeros was 2025 -656,038.76 USD. It decreases by -27.45% higher compared to the previous year.
Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

EBIT per Employee of Omeros is -475,953.49 USD in 2026.

EBIT per Employee of Omeros changed from -656,038.76 USD to -475,953.49 USD, representing a -27.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Omeros since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Omeros historically and in real time.

Access this data via the Eulerpool API

Workforce — Omeros

All Key Metrics — Omeros